Jakarta, July 13 -- The Food and Drug Monitoring Agency (BPOM) is taking regulatory and collaborative measures to safeguard the supply of pharmaceutical raw materials in Indonesia amid renewed geopolitical tensions affecting the Strait of Hormuz.

BPOM Head Taruna Ikrar explained that 90 percent of pharmaceutical raw materials in Indonesia are still imported. These materials consist of three types: raw materials, intermediate materials, and finished materials, but are repackaged in Indonesia.

"We understand that our national pharmaceutical needs are part of national resilience. If medicines are insufficient, it endangers our health and national security," he stated on Monday.

To reduce this dependence, Ikrar said BPOM is improving regul...